MYC and Miyoshi myopathy: The primary tumor-initiating events include genetic translocation and hyperploidy, while secondary events, such as oncogenic c-Myc activation and overexpression, drive MM progression (Bergsagel and Kuehl, 2005; Morgan et al., 2012).